ReviewZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review].

P P Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.